Delivery Order SPE2DB20D3303-SPE2DB25FA4EG
Award Date 9/24/25
Potential Completion Date 9/25/25
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $47,526.27 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count units). This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,368 delivery order to AmerisourceBergen Drug Corp for Deferasirox 360 mg granule packets (30 count) on September 10, 2025, with a completion date of September 11, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The award was competitively awarded without set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 360 mg Deferasirox tablets (30-count units) on May 16, 2025, with a ceiling value of $5,673.37 and an ultimate completion date of May 19, 2025. This is a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award represents a competitive, non-set-aside...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,991.52 to AmerisourceBergen Drug Corp for Deferasirox 500 mg tablets for suspension (30-count units) on September 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and is scheduled for completion by September 25, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Deferasirox 500 mg tablets for suspension. The contract has a ceiling value of $2,455.30 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under a larger...
- This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract is for the delivery of Deferasirox 500 mg tablets for suspension, with a completion date of February 1, 2024 and a potential value of $2,946.36. The contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as a major...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,063.08, is for the delivery of Deferiprone 1,000 mg tablets to support military healthcare programs. The contract is a firm-fixed price type, with an ultimate completion date of January 18, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp in the amount of $25,052.94 for the supply of Deferiprone 1,000 mg tablets. The contract has a firm fixed price and provides for the delivery of this pharmaceutical product through June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, supports the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $6,453.60 from the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of Injectafer 750 mg/15 mL vials. The contract is classified as a child award under a firm fixed-price delivery order arrangement with an ultimate completion date of June 20, 2025. No set-aside designation was applied to this award, indicating it was competitively awarded...